Research & Treatment News

Top Drug Companies Agree to Joint Study for All-Oral Hep C Treatment

Apr 11, 2013

Two leading pharmaceutical companies, Vertex and Bristol-Myers Squibb, have agreed to work together towards their common goal – an all-oral Hepatitis C treatment.

Dental Practice Possibly Exposes 7,000 Patients to Hepatitis and HIV

Apr 3, 2013

Find out how a dental practice in Tulsa, Oklahoma may have exposed thousands of people to Hepatitis B, Hepatitis C and HIV over the course of six years.

Phase 3 Trial of ION-1 Will Continue

Mar 28, 2013 1 Comment

Learn more about the phase 3 trial by Gilead Sciences Inc., which is evaluating once-daily fixed-dose combination of the nucleotide sofosbuvir and the NS5A inhibitor ledipasvir.

Can Miravirsen Stop HCV with Little Side Effects?

Mar 28, 2013

Discover why the most recent study on miravirsen offers hope for people with Hepatitis C.

A Single-Shot-Cure for Hepatitis C Being Tested at Duke

Mar 28, 2013 3 Comments

A potential single-injection-cure for Hepatitis C, Benitec’s revolutionary TT-034 will soon be tested in previous non-responders at Duke Clinical Research Institute.

Holding Out for Better Hepatitis C Treatment

Mar 22, 2013 13 Comments

Riddled with hard personal decisions and ethical quandaries, many people are opting to pass on current Hepatitis C therapy. Instead, they are waiting for the arrival of an interferon-free drug regimen that is still in development.